Aier Eye Hospital Group Plans $100 Million Innovation Fund to Accelerate Mobile Health and Ophthalmic Tech Ventures

Recently, Aier Eye Hospital Group proposed to establish the Aier Incubation Fund as an investment and incubation platform for its innovation and entrepreneurship ecosystem in ophthalmology and visual science. The fund is planned to have a size of USD 100 million, with specific investment amounts determined based on the progress of project investment and incubation. Its investment and incubation focus will primarily target innovative high-growth enterprises or projects in ophthalmology, visual science, and related fields (including innovative diagnostic and therapeutic technologies, precision medicine, and mobile health) that also demonstrate broad market prospects.

As early as last year, Aier Eye Hospital invested RMB 200 million to establish a wholly-owned subsidiary in Hong Kong, serving as an investment platform for its overseas medical services industry. This move aims to introduce new overseas technologies and business models, leverage internationally leading resources to foster its own development, and enhance the company’s core competitiveness and global influence.

Premium Brands Accelerate the Rapid Growth of Incubated Enterprises

Aier Eye Hospital Group is China’s first medical institution to go public via an initial public offering (IPO) and the first medical brand to be recognized as a Well-Known Trademark. Its network of 100 chain eye hospitals constitutes the largest ophthalmic medical organization in China, making it the country’s leading eye hospital provider for myopia correction.

In 2013, Aier Eye Hospital Group jointly established the Aier School of Ophthalmology at Central South University. As China’s first institution dedicated to cultivating elite professionals in ophthalmology, the school has recruited renowned professors in ophthalmology and the eye care industry from across China, including Academician Yang Xiongli of the Chinese Academy of Sciences and Professor Su Guohui.

On this occasion, Aier Eye Hospital established a review committee comprising its affiliated professional institutions—including the Aier School of Ophthalmology at Central South University, the Aier Eye Research Institute, and the Aier Institute of Optometry and Vision Science—as well as leading global experts in ophthalmology and vision science. This committee efficiently screened high-quality projects characterized by core innovative capabilities and potential for high returns. By leveraging its strong brand influence and promotional capabilities, Aier Eye Hospital deeply integrated with the selected high-quality incubation projects to accelerate the rapid growth of these incubated enterprises. This strategy not only ensures a high return on investment for the fund but also reserves high-quality project targets for the company’s future innovative development in the field of ophthalmology.

Multi-Angle Layout: Building a New Landscape for Mobile Healthcare

On August 29, the company announced its plan to formulate and implement the “Aier Eye Hospital Mobile Healthcare Development Plan,” with the goal of building an all-encompassing “Eye Health Assurance System” that integrates online and offline services, medical care and prevention, and in-hospital and out-of-hospital coordination. The plan states that the company will continue to invest in the development of intelligent ophthalmic equipment and leverage technologies such as telemedicine and mobile internet to create a new model of eye health services that integrates channel management, consultation, examination, treatment, rehabilitation, healthcare, and education.

Chen Bang, Chairman of the Company, stated that moving forward, mobile healthcare will be cultivated as a core strategic competency in the new era. By leveraging the company’s current unique advantages in offline medical services and deeply integrating with “Internet Plus,” the company aims to establish new competitive strengths in the era of mobile healthcare.

As Chen Bang stated, Aier Eye Hospital has strategically positioned itself in mobile healthcare from multiple perspectives and has already taken concrete actions.

Establish a unified IT infrastructure based on “cloud architecture” to provide robust IT support for mobile healthcare, enhance the clinical and technical capabilities of hospitals at all levels, and improve the service experience for customers across regions. Coverage of offline Hospital Information Systems (HIS) has now been largely achieved;

Investing in the development of smart ophthalmic devices and R&D leveraging telemedicine,Mobile Internet...and other technologies and methods to create a new O+O model for eye health services. It has invested in Hunan Jishi Interconnected Technology Co., Ltd. to extend and expand the primary care entry point for mobile healthcare;

Strategically positioned in fields such as intelligent image recognition, iris recognition, big data, artificial intelligence, smart healthcare, and the Internet of Things (IoT), we provide diversified and innovative eye health services. To date, we have invested in Jingzhijing Technology and JinHong Technology; developed the “Intelligent Ophthalmic Image Reading and Management System” and the “Aier AR Glasses Virtual Try-On System”; invested in Beijing Chunyu Tianxia Technology Co., Ltd.; and initiated the establishment of the Chunfeng-Aier Mobile Healthcare Special Fund.

VCBeat synthesized information from Southwest Securities, the Shanghai Securities News, and other sources.